Red Lighthouse Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Red Lighthouse Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-222	Closed	-$37.5K	–	97
2025 Q4	$37.5K	Hold	222	–	–	0.01%	83
2025 Q3	$32K	Hold	222	–	–	0.01%	106
2025 Q2	$28.1K	Hold	222	–	–	0.01%	107
2025 Q1	$30.5K	Hold	222	–	–	0.01%	99
2024 Q4	$29.4K	Hold	222	–	–	0.01%	104
2024 Q3	$32.3K	Hold	222	–	–	0.01%	101
2024 Q2	$30.5K	Hold	222	–	–	0.01%	100
2024 Q1	$30.5K	Hold	222	–	–	0.01%	99
2023 Q4	$30.2K	Hold	222	–	–	0.01%	95
2023 Q3	$27.1K	Hold	222	–	–	0.01%	90
2023 Q2	$28.2K	Hold	222	–	–	0.01%	91
2023 Q1	$28.7K	Sell	222 -78	-26%	-$10.2K	0.01%	89
2022 Q4	$39.4K	Buy	+300	New	+$38.8K	0.02%	88

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Red Lighthouse Investment Management's IBB Position: Q1 2026 in Review

Red Lighthouse Investment Management sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 222 shares — an estimated $37.5K sold.

Red Lighthouse Investment Management first reported a position in IBB in Q4 2022 and held it in 13 quarters. The position peaked at $39.4K in Q4 2022. 924 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Red Lighthouse Investment Management reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
Red Lighthouse Investment Management sold 222 iShares Biotechnology ETF shares in Q1 2026, an estimated $37.5K.
Red Lighthouse Investment Management first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 13 quarters.
Red Lighthouse Investment Management's iShares Biotechnology ETF position peaked at $39.4K in Q4 2022.
924 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Red Lighthouse Investment Management's 13F filing for Q1 2026, filed 8 May 2026.